Myasthenia syndrome during penicillamine treatment.
D000293:Adolescent; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced*; D010396:Penicillamine / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors
D010396:Penicillamine